High Throughput Screening Market

High Throughput Screening Market by Technology (Cell-Based Assays, Lab on a Chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent, Instruments, Software, Service), End User - Global Forecast to 2023

Report Code: BT 2220 Apr, 2018, by marketsandmarkets.com

[244 Pages Report] The high-throughput screening market was valued at USD 13.87 Billion in 2017 and is expected to reach USD 21.69 Billion in 2023, at a CAGR of 7.8% during the forecast period. The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological improvements in HTS, and the availability of government funding and venture capital investments. The base year considered for the study is 2017 and the forecast period includes 2018 to 2023. However, the overall use and adoption of HTS and associated instruments face challenges in the form of a dearth of skilled operators to use them and the costly and time-consuming nature of HTS techniques.

High-Throughput Screening Market:Breakdown of Primaries

Helped a top global leader to identify approximately USD 6 billion revenue potential by tapping into the high-throughput screening market for target identification and validation.

Client’s Problem Statement

Our client, a leader in high-throughput screening technology infrastructure, was keen to build a substantive global business in the high-throughput screening market for target identification and validation. The client requested MarketsandMarkets to define, describe, and forecast the global high-throughput screening market for target identification and validation on the basis of types of instruments—microplate readers, mass spectrophotometers, flow cytometers, and other instruments. In addition, the market was split into high-throughput screening for target identification and validation by type of screening—GPCR screening, enzyme screening, and ion channel screening—across five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

MnM Approach

MnM conducted a multi-level qualitative and quantitative study with a constructed sample of mid- to senior-level management executives (directors, supply chain executives, and business managers) and healthcare stakeholders (pharmaceutical companies, contract research organizations, and consultants). Key parameters influencing the market were identified and the relevant trends were studied to obtain accurate market data. At every level, the estimates were verified by interviews with industry experts (from both demand and supply sides) as well as by MarketsandMarkets domain experts. Both top-down and bottom-up approaches were used to ensure unbiased data. Further, MnM also helped the client to build an understanding of the competitive landscape, varying business models, and strategies of different players in stem cell manufacturing. Market share analysis was conducted for the top four players in the market. This helped the client to devise a differentiated product offering and forge suitable alliances in order to win in this market.

Revenue Impact (RI)

Helped a top global leader to identify approximately USD 6 billion revenue potential by tapping into the high-throughput screening market for target identification and validation.

Consult our Analyst now

Software segment is expected to register the highest CAGR during the forecast period.

On the basis of products & services, the high-throughput screening market is segmented into instruments, reagents & assay kits, consumables & accessories, software, and services. Of all these segments, reagents and assay kits accounted for the largest share of the HTS market in 2017. The large share of this market segment can primarily be attributed to factors such as the large numbers of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research. The software segment, on the other hand, is expected to be the fastest-growing segment of the HTS market. Market growth can largely be attributed to the increasing automation of high-throughput screening and the availability of data management software tools, which enable researchers to develop systematic and process-oriented approaches toward HTS techniques.

Label-free technology segment to grow at the highest CAGR during 2017 to 2022.

On the basis of technology, the HTS market is segmented into cell-based assays (2D cell culture, 3D cell culture), lab-on-a-chip (LOC), ultra-high-throughput screening (uHTS), label-free technology, and bioinformatics. The label-free technology market is expected to register the highest CAGR during the forecast period followed by lab-on-a-chip market. Advancements in label-free instruments have led to improvements in the cost, throughput, sensitivity, and level of data analysis. The recent trend towards the use of biologically relevant assays is bound to present a large opportunity for label-free technologies. The major advantage offered by label-free technology is that it can help in the study of varied cell types and targets. Label-free assays also provide simple methods for studying complex biological pathways. The label-free technology is set to reduce drug failure caused by toxicity. These factors are likely to boost the growth of this technology market.

3D cell culture market is expected to grow at highest CAGR among the cell-based assays market. The highest growth of this segment is attributed to the increasing adoption of 3D cell culture among the research laboratories, academic institutes, hospitals, and biopharmaceutical & biotechnology companies.

Pharmaceutical and biotechnology companies to dominate the market share

The global high-throughput screening market is categorized into four major end-user segments, namely, pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture, & environmental industries). In 2017, the pharmaceutical and biotechnology companies segment accounted for the largest share of the global HTS market. The large share of this segment is primarily attributed to the extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications along with the increasing pharmaceutical R&D expenditure.

APAC is projected to witness the highest growth during the forecast period.

North America accounts for a major share of the market, primarily due to the large spending on pharmaceutical R&D and the growing adoption of HTS and availability of government funding in this region. However, the market in Asia-Pacific is expected to grow at the highest rate from 2018 to 2023. Increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding are some factors driving this growth.

High-Throughput Screening Market:Breakdown of Primaries

North America to account for the largest market size during the forecast period.

North America is the largest market for high-throughput screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In addition, this region has shown strong commercialization of pharmaceutical and biotechnology research. The generic manufacturers need HTS platforms for hit identification and target validation in drug discovery and development. According to the US Food and Drug Administration (FDA), the total number of generic drug approvals in 2014 was 409, which increased to 763 in 2017. The increased focus on generic medicines is also expected to aid the growth of the HTS market in this region.

High-Throughput Screening Market:Breakdown of Primaries

Market Dynamics

Driver: Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies

In recent years, the pharmaceutical and biotechnology industries have adopted open innovation approaches for collaborating on drug discovery processes with academic and research institutions. In this open innovation approach, academic organizations carry out target identification and validation research, while pharmaceutical companies conduct HTS assay development and specialized screening campaigns. This approach is beneficial for both pharmaceutical companies as well as the academia. A collaborative approach covers the determination of basic biology of targets of therapeutic value, new target identification, and replacement stem cell therapies.

Through this approach, pharmaceutical companies can accelerate their drug discovery by improving research efficiency and output, while academic institutes can further their research with the help of large datasets present in the public domain of large pharmaceutical companies. For instance, in August 2017, the Medical Research Council Laboratory of Molecular Biology (UK) entered into an innovative collaboration with UCB (Belgium) and AstraZeneca (UK) to speed drug discovery research by providing its academic researchers with industry infrastructure and expertise. Similarly, in December 2015, Axxam S.p.A (Italy), a leading provider of integrated discovery services for life sciences industries entered into a research collaboration with the Neurodegeneration Consortium at The University of Texas to identify and develop novel small-molecule modulators of an undisclosed G-protein coupled receptor for Alzheimer’s disease. Through this collaboration, the Neurodegeneration Consortium will access Axxam’s HTS platforms for research. The increasing adoption of HTS in pharmaceutical & biotechnology companies and academic & research institutes is thus expected to fuel the growth of the HTS market.

Restraint: Capital-Intensive Nature of HTS

HTS involves a number of steps such as target selection and characterization, reagent preparation, assay development, compound screening, and hit validation in secondary assays. The time and cost involved in each process vary according to the complexity of the target and assay. The process of reagent and assay development for primary and secondary makes it more expensive. In addition, HTS instruments, such as flow cytometers and liquid handlers, are costly; the price of a flow cytometer varies from USD 35,000 for simple cell analyzers to above USD 300,000 for more complex systems with higher throughput. The CyFlow Cube 6 from Sysmex-Partec costs around USD 35,000. The S3 cell sorter from Bio-Rad Laboratories is priced at USD 150,000 while BD’s FACSJazz costs around USD 240,000. A workstation, such as a liquid handler, is equipped with advanced features and functionalities and is premium-priced. The price of one workstation ranges from USD 10,000 to USD 100,000 depending on its sophistication. Systems with robotic arms can cost more than USD 100,000.

Academic research laboratories find it difficult to afford such instruments, as they have restricted budgets. On the other hand, pharmaceutical companies require many such systems, and hence their capital costs increase significantly. Moreover, the maintenance costs and several other indirect expenses increase the total cost of ownership of these instruments. High cost, therefore, hinders the wide adoption of HTS instruments in both clinical and research applications.

Opportunity: Growing research activities in toxicology and stem cells

High-throughput cell-based screening assays are routinely used in toxicology studies and stem cell research. Miniaturized cell-based assays with high-throughput capabilities can identify toxic compounds early in the process of drug discovery, thereby saving enormous financial resources. Many government research organizations utilize HTS for toxic compounds. For instance, the US NIH, in collaboration with the US FDA and EPA, introduced the “Toxicology in the 21st Century (Tox21)” program, which uses automated HTS to test environmental chemicals, drugs, and formulations for in-depth toxicological evaluation and the development of disease-associated and predictive toxicological pathways. The increased utilization of the HTS technique in the field of toxicology will prove to be beneficial in the long run.

HTS is used in stem cell research for the identification of target hits; investigation of functional activity; and the assessment of absorption, distribution, metabolism, and excretion characteristics. The use of human stem cells instead of mouse stem cells provides opportunities for improving the clinical predictability of preclinical drug discovery and development. Humanized stem cell-based HTS and assays thus possess the potential to revolutionize drug discovery and development. As a result, their use is expected to increase in the coming years, which provides growth opportunities in this market.

Challenge: Dearth of skilled operators

HTS instruments such as flow cytometers, liquid handling systems, and multimode readers are relatively complex technologies and require expertise to be handled effectively.

However, there is a significant shortage of skilled personnel. A survey conducted by the Association of the British Pharmaceutical Industry (ABPI) in 2015 in the UK revealed a lack of skilled personnel in pharmaceutical companies. Around 93 employees from 59 pharmaceutical companies participated in the survey. More than 50% respondents in the survey expressed an urgent need to improve the availability of staff in 10 discipline areas. Owing to the shortage of skilled and knowledgeable professionals, companies tend to prefer conventional screening methods to cell-based assays; this presents a significant challenge to the growth of the HTS market.

Scope of the report

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Million (USD)

Segments covered

By Technology (Cell-Based Assays, Lab on a Chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent, Instruments, Software, Service), End User

Geographies covered

North America, Europe, APAC, Latin America, and MEA

Companies covered

Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan Group (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton Company (US), Corning Incorporated (US), BioTek Instruments (US), and Aurora Biomed (Canada)

The research report categorizes the High Throughput Screening market to forecast the revenues and analyze the trends in each of the following sub-segments:

High-Throughput Screening Market, By Product & Service

  • Reagents & Assay Kits
  • Instruments
  • Consumables & Accessories
  • Software
  • Services

High-Throughput Screening Market, By Technology

  • Cell-Based Assays
    • 2d Cell Culture
    • 3d Cell Culture
      • Scaffold-Based Technology
        • Hydrogels
          • Animal-Derived Hydrogels
          • Matrigel
          • Collagen
          • Synthetic Hydrogels
          • Alginate/Agarose
          • Inert Matrix/Solid Scaffolds
          • Micropatterned Surfaces
      • Scaffold-Free Technology
        • Microplates
        • Hanging-Drop Plates
        • Ultra-Low Binding Plates
        • Other Scaffold-Free Technologies
    • Perfusion Cell Culture
    • Reporter Based Assays
  • Lab-On-A-Chip
  • Ultra-High-Throughput Screening
  • Bioinformatics
  • Label-Free Technology

High-Throughput Screening Market, By Application

  • Drug Discovery
    • Target Identification and Validation
    • Primary and Secondary Screening
    • Toxicology Assessment
  • Chemical Biology Programs
  • Cell- & Organ-Based Screening
  • Biochemical Screening
  • Biological Active Compound Screening
  • Genomics
  • Proteomics
  • Compound Profiling

High-Throughput Screening Market, By Detection Method

  • Mass Spectrometry (MS)
  • Chromatography
  • Calorimetry
  • X-Ray Diffraction
  • Other Detection Methods

High-Throughput Screening Market, By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations (CRO)
  • Other End Users

High-Throughput Screening Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Latin America
  • Middle East & Africa

Key Market Players

Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan Group (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton Company (US), Corning Incorporated (US), BioTek Instruments (US), and Aurora Biomed (Canada).

Thermo Fisher Scientific is one of the prominent players in the high-throughput screening market. In order to sustain its strong position in this market, the company majorly focuses on its capabilities in technologies, software, and services. The company also has an extensive distribution channel across the globe. As a part of its business strategy, the company concentrates on establishing a strong relationship with pharmaceutical manufacturers, academic institutes, research institutes, and laboratories across the globe. The company offers various products to accelerate research activity, solve complex analytical challenges, improve diagnostic capabilities, and strengthen laboratory productivity. The company majorly focuses on acquisitions and agreements to enhance its presence in the high-throughput screening market. For instance, in January 2018, the company agreed with Illumina, Inc. (US), to provide Illumina with the Ion AmpliSeq technology required for research on next-generation sequencing. In addition, in August 2017, the company acquired Patheon N.V. (Netherlands), to strengthen its customer base. In addition to this, the company also focuses on organic strategies to garner a larger market share. For instance, in 2018, the company launched its Axiom Microbiome Array and Ion GeneStudio S5 Series.

Recent Developments

  • In 2017, Thermo Fisher Scientific acquired Patheon for USD 7.2 billion. This acquisition helped the company to strengthen its customer base.
  • In 2018, Thermo Fisher Scientific signed agreement with Illumina, Inc. (US) to provide Illumina with the Ion AmpliSeq technology required for research on next-generation sequencing
  • In 2016, Agilent Technologies established a new Technology Center in Folsom, California, for USD 14.7 million. This technology center will employee approximately 60 staff member and will particularly focus on the company’s Intuvo 9000 GC system and its consumables.
  • In 2018, Agilent Technologies (US) acquired Luxcel Biosciences Limited (Ireland). This acquisition expanded the company’s cell analysis portfolio by providing easy-to-use assay kits which are compatible with standard plate readers. The company also expanded its pharma/biopharma discovery and in vitro toxicology screening applications.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the high throughput screening market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 HCS Market Definition
    1.3 Scope of the Study
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Report
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology
    2.1 Research Approach
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
    4.1 High-Throughput Screening: Market Overview
    4.2 HTS Market: Developed vs Developing Countries (2018 vs 2023)
    4.3 Geographic Snapshot: HTS Market (2017)
    4.4 Geographic Mix: HTS Market
    4.5 HTS Market, By Product & Services (2018 vs 2023)

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
                    5.2.1.2 Government Funding and Venture Capital Investments
                    5.2.1.3 Increasing R&D Spending
                    5.2.1.4 Technological Advancements
           5.2.2 Market Restraints
                    5.2.2.1 Capital-Intensive Nature of Hts
                    5.2.2.2 Complexities in the Field of Assay Development
           5.2.3 Market Opportunities
                    5.2.3.1 Emerging Markets
                    5.2.3.2 Growing Research Activities in Toxicology and Stem Cells
           5.2.4 HCS Market Challenges
                    5.2.4.1 Dearth of Skilled Operators

6 Industry Insights
    6.1 Introduction
    6.2 Technological Trends
           6.2.1 Label-Free Technology
           6.2.2 Automation & Miniaturization
           6.2.3 Microfluidics
    6.3 HTS in Drug Discovery Process

7 High-Throughput Screening Market, By Product & Service
    7.1 Introduction
    7.2 Reagents & Assay Kits
    7.3 Instruments
    7.4 Consumables & Accessories
    7.5 Software
    7.6 Services

8 High-Throughput Screening Market, By Technology
    8.1 Introduction
    8.2 Cell-Based Assays
           8.2.1 2D Cell Culture
           8.2.2 3D Cell Culture
                    8.2.2.1 Scaffold-Based Technology
                               8.2.2.1.1 Hydrogels
                                             8.2.2.1.1.1 Animal-Derived Hydrogels
                                                            8.2.2.1.1.1.1 Matrigel
                                                            8.2.2.1.1.1.2 Collagen
                                             8.2.2.1.1.2 Synthetic Hydrogels
                                             8.2.2.1.1.3 Alginate/Agarose
                               8.2.2.1.2 Inert Matrix/Solid Scaffolds
                               8.2.2.1.3 Micropatterned Surfaces
                    8.2.2.2 Scaffold-Free Technology
                               8.2.2.2.1 Microplates
                               8.2.2.2.2 Hanging-Drop Plates
                               8.2.2.2.3 Ultra-Low Binding Plates
                               8.2.2.2.4 Other Scaffold-Free Technologies
           8.2.3 Perfusion Cell Culture
           8.2.4 Reporter Based Assays
    8.3 Lab-On-A-Chip
    8.4 Ultra-High-Throughput Screening
    8.5 Bioinformatics
    8.6 Label-Free Technology

9 High-Throughput Screening Market, By Application
    9.1 Introduction
    9.2 Drug Discovery 
           9.1.1 Target Identification And Validation
           9.1.2 Primary And Secondary Screening
           9.1.3 Toxicology Assessment
    9.2 Chemical Biology Programs
    9.3 Cell- & Organ-Based Screening
    9.4 Biochemical Screening
    9.5 Biological Active Compound Screening
    9.6 Genomics
    9.7 Proteomics
    9.8 Compound Profiling

10 High-Throughput Screening Market, By Detection Method 
     10.1 Introduction
     10.2 Mass Spectrometry (MS)
     10.3 Chromatography
     10.4 Calorimetry
     10.5 X-Ray Diffraction
     10.6 Other Detection Methods

11 High-Throughput Screening Market, By End User
     11.1 Introduction
     11.2 Pharmaceutical And Biotechnology Companies
     11.3 Academic and Government Institutes
     11.4 Contract Research Organizations (CRO)
     11.5 Other End Users

12 High-Throughput Screening Market, By Region
     12.1 Introduction
     12.2 North America
             12.2.1 US
             12.2.2 Canada
     12.3 Europe
             12.3.1 Germany
             12.3.2 UK
             12.3.3 France
             12.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest Of Europe
     12.4 Asia Pacific
             12.4.1 Japan
             12.4.2 China
             12.4.3 India
             12.4.4 Rest Of Asia Pacific
     12.5 Latin America
     12.6 Middle East And Africa

13 Competitive Landscape
     13.1 Introduction
     13.2 Market Leadership Analysis
     13.3 Competitive Scenario
             13.3.1 Product Launches And Upgrades
             13.3.2 Partnerships, Collaborations, And Agreements
             13.3.3 Expansions
             13.3.4 Acquisitions
             13.3.5 Other Developments

14 Company Profiles
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)* 
     14.1 Thermo Fisher Scientific Inc.
             14.1.1 Business Overview
             14.1.2 Products Offered
             14.1.3 Recent Developments
             14.1.4 SWOT Analysis
             14.1.5 MnM View
     14.2 Agilent Technologies, Inc.
             14.2.1 Business Overview
             14.2.2 Products Offered
             14.2.3 Recent Developments
             14.2.4 SWOT Analysis
             14.2.5 MnM View
     14.3 Danaher Corporation
             14.3.1 Business Overview
             14.3.2 Products Offered
             14.3.3 Recent Developments
             14.3.4 SWOT Analysis
             14.3.5 MnM View
     14.4 Perkinelmer, Inc.
             14.4.1 Business Overview
             14.4.2 Products Offered
             14.4.3 Recent Developments
             14.4.4 SWOT Analysis
             14.4.5 MnM View
     14.5 Tecan Group
             14.5.1 Business Overview
             14.5.2 Products Offered
             14.5.3 Recent Developments
             14.5.4 SWOT Analysis
             14.5.5 MnM View
     14.6 Axxam S.P.A.
             14.6.1 Business Overview
             14.6.2 Products Offered
             14.6.3 Recent Developments
             14.6.4 SWOT Analysis
             14.6.5 MnM View
     14.7 Bio-Rad Laboratories
             14.7.1 Business Overview
             14.7.2 Products Offered
             14.7.3 Recent Developments
             14.7.4 MnM View
     14.8 Merck Group
             14.8.1 Business Overview
             14.8.2 Products Offered
             14.8.3 Recent Developments
             14.8.4 MnM View
     14.9 Hamilton Company
             14.9.1 Business Overview
             14.9.2 Products Offered
             14.9.3 Recent Developments
             14.9.4 MnM View
     14.10 Corning Incorporated
             14.10.1 Business Overview
             14.10.2 Products Offered
             14.10.3 Recent Developments
             14.10.4 MnM View
     14.11 Biotek Instruments
             14.11.1 Business Overview
             14.11.2 Products Offered
             14.11.3 Recent Developments
             14.11.4 MnM View
     14.12 Aurora Biomed
             14.12.1 Business Overview
             14.12.2 Products Offered
             14.12.3 Recent Developments
             14.12.4 MnM View
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies. 

15 Appendix
      15.1 Discussion Guide
      15.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
      15.3 Introducing Rt: Real-Time Market Intelligence
      15.4 Available Customizations
      15.5 Related Reports
      15.6 Author Details


List of Tables (233 Tables)

Table 1 Increase in Company R&D Expenditure (2014–2016)
Table 2 Impact Analysis: High-Throughput Screening Market Drivers
Table 3 Impact Analysis: High-Throughput Screening Market Restraints
Table 4 Impact Analysis: High-Throughput Screening Market Opportunities
Table 5 Impact Analysis: High-Throughput Screening Market Challenges
Table 6 High-Throughput Screening Market, By Product & Service, 2016–2023 (USD Million)
Table 7 High-Throughput Screening Reagents & Assay Kits Market, By Region, 2016–2023 (USD Million)
Table 8 High-Throughput Screening Instruments Market, By Country, 2016–2023 (USD Million)
Table 9 High-Throughput Screening Consumables & Accessories Market, By Region, 2016–2023 (USD Million)
Table 10 High-Throughput Screening Software Market, By Region, 2016–2023 (USD Million)
Table 11 High-Throughput Screening Services Market, By Region, 2016–2023 (USD Million)
Table 12 High-Throughput Screening Market, By Technology, 2016–2023 (USD Million)
Table 13 Cell-Based Assays High-Throughput Screening Market, By Type, 2016–2023 (USD Million)
Table 14 Cell-Based Assays High-Throughput Screening Market, By Country, 2016–2023 (USD Million)
Table 15 Cell-Based Assays High-Throughput Screening Market for 2D Cell Culture, By Country, 2016–2023 (USD Million)
Table 16 Cell-Based Assays High-Throughput Screening Market for 3D Cell Culture, By Type, 2016–2023 (USD Million)
Table 17 Cell-Based Assays High-Throughput Screening Market for 3D Cell Culture, By Country, 2016–2023 (USD Million)
Table 18 High-Throughput Screening Market for Scaffold-Based Technology, By Type, 2016–2023 (USD Million)
Table 19 Global High-Throughput Screening Market for Scaffold-Based Technology, By Country, 2016–2023 (USD Million)
Table 20 High-Throughput Screening Market for Hydrogels, By Type, 2016–2023 (USD Million)
Table 21 Global High-Throughput Screening Market for Hydrogels, By Country, 2016–2023 (USD Million)
Table 22 High-Throughput Screening Market for Animal-Derived Hydrogels, By Type, 2016–2023 (USD Million)
Table 23 Global High-Throughput Screening Market for Animal-Derived Hydrogels, By Country, 2016–2023 (USD Million)
Table 24 High-Throughput Screening Market for Matrigel, By Country, 2016–2023 (USD Million)
Table 25 Global High-Throughput Screening Market for Collagen, By Country, 2016–2023 (USD Million)
Table 26 High-Throughput Screening Market for Synthetic Hydrogels, By Country, 2016–2023 (USD Million)
Table 27 Global High-Throughput Screening Market for Alginate/Agarose, By Country, 2016–2023 (USD Million)
Table 28 High-Throughput Screening Market for Inert Matrix/Solid Scaffolds, By Country, 2016–2023 (USD Million)
Table 29 Global High-Throughput Screening Market for Micropatterned Surfaces, By Country, 2016–2023 (USD Million)
Table 30 High-Throughput Screening Market for Scaffold-Free Technology, By Type, 2016–2023 (USD Million)
Table 31 Global High-Throughput Screening Market for Scaffold-Free Technology, By Country, 2016–2023 (USD Million)
Table 32 High-Throughput Screening Market for Microplates, By Country, 2016–2023 (USD Million)
Table 33 Global High-Throughput Screening Market for Hanging-Drop Plates, By Country, 2016–2023 (USD Million)
Table 34 High Content Screening Market for Ultra-Low Binding Plates, By Country, 2016–2023 (USD Million)
Table 35 Global Market for Other Scaffold-Free Technologies, By Country, 2016–2023 (USD Million)
Table 36 HCS Market for Perfusion Cell Culture, By Country, 2016–2023 (USD Million)
Table 37 Global HCS Market for Lab-On-A-Chip, By Country, 2016–2023 (USD Million)
Table 38 Ultra-Market, By Country, 2016–2023 (USD Million)
Table 39 Global HCS Market for Bioinformatics, By Country, 2016–2023 (USD Million)
Table 40 High Content Screening Market for Label-Free Technology, By Country, 2016–2023 (USD Million)
Table 41 Global Market, By Application, 2016–2023 (USD Million)
Table 42 HCS Market for Target Identification and Validation, By Country, 2016–2023 (USD Million)
Table 43 Global Market for Primary and Secondary Screening, By Country, 2016–2023 (USD Million)
Table 44 HCS Market for Toxicology Assessment, By Country, 2016–2023 (USD Million)
Table 45 Global Market for Other Applications, By Country, 2016–2023 (USD Million)
Table 46 Market, By End User, 2016–2023 (USD Million)
Table 47 Global HCS Market for Pharmaceutical and Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 48 Market for Academic and Government Institutes, By Country, 2016–2023 (USD Million)
Table 49 Global Market for Contract Research Organizations, By Country, 2016–2023 (USD Million)
Table 50 HCS Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 51 Global Market, By Region, 2016–2023 (USD Million)
Table 52 North America: Market, By Country, 2016–2023 (USD Million)
Table 53 North America: HCS Market, By Technology, 2016–2023 (USD Million)
Table 54 North America: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 55 North America: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 56 North America: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 57 North America: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 58 North America: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 59 North America: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 60 North America: Market, By Application, 2016–2023 (USD Million)
Table 61 North America: HCS Market, By Product and Service, 2016–2023 (USD Million)
Table 62 North America: Market, By End User, 2016–2023 (USD Million)
Table 63 Nih Budget for Various Disciplines in 2015 and 2016
Table 64 US: Market, By Technology, 2016–2023 (USD Million)
Table 65 US: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 66 US: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 67 US: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 68 US: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 69 US: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 70 US: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 71 US: HCS Market, By Application, 2016–2023 (USD Million)
Table 72 US: Market, By Product and Service, 2016–2023 (USD Million)
Table 73 US: HCS Market, By End User, 2016–2023 (USD Million)
Table 74 Canada: HCS Market, By Technology, 2016–2023 (USD Million)
Table 75 Canada: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 76 Canada: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 77 Canada: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 78 Canada: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 79 Canada: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 80 Canada: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 81 Canada: Market, By Application, 2016–2023 (USD Million)
Table 82 Canada: Market, By Product and Service, 2016–2023 (USD Million)
Table 83 Canada: Market, By End User, 2016–2023 (USD Million)
Table 84 Europe: Pharmaceutical R&D Expenditure, By Country, 2015 (USD Million)
Table 85 Europe: Market, By Country, 2016–2023 (USD Million)
Table 86 Europe: Market, By Technology, 2016–2023 (USD Million)
Table 87 Europe: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 88 Europe: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 89 Europe: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 90 Europe: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 91 Europe: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 92 Europe: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 93 Europe: Market, By Application, 2016–2023 (USD Million)
Table 94 Europe: Market, By Product and Service, 2016–2023 (USD Million)
Table 95 Europe: Market, By End User, 2016–2023 (USD Million)
Table 96 Germany: Market, By Technology, 2016–2023 (USD Million)
Table 97 Germany: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 98 Germany: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 99 Germany: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 100 Germany: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 101 Germany: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 102 Germany: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 103 Germany: Market, By Application, 2016–2023 (USD Million)
Table 104 Germany: Market, By Product and Service, 2016–2023 (USD Million)
Table 105 Germany: Market, By End User, 2016–2023 (USD Million)
Table 106 UK: Market, By Technology, 2016–2023 (USD Million)
Table 107 UK: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 108 UK: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 109 UK: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 110 UK: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 111 UK: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 112 UK: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 113 UK: Market, By Application, 2016–2023 (USD Million)
Table 114 UK: Market, By Product and Service, 2016–2023 (USD Million)
Table 115 UK: Market, By End User, 2016–2023 (USD Million)
Table 116 France: Market, By Technology, 2016–2023 (USD Million)
Table 117 France: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 118 France: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 119 France: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 120 France: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 121 France: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 122 France: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 123 France: Market, By Application, 2016–2023 (USD Million)
Table 124 France: Market, By Product and Service, 2016–2023 (USD Million)
Table 125 France: Market, By End User, 2016–2023 (USD Million)
Table 126 Italy: Market, By Technology, 2016–2023 (USD Million)
Table 127 Italy: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 128 Italy: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 129 Italy: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 130 Italy: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 131 Italy: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 132 Italy: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 133 Italy: Market, By Application, 2016–2023 (USD Million)
Table 134 Italy: Market, By Product and Service, 2016–2023 (USD Million)
Table 135 Italy: Market, By End User, 2016–2023 (USD Million)
Table 136 Spain: Market, By Technology, 2016–2023 (USD Million)
Table 137 Spain: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 138 Spain: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 139 Spain: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 140 Spain: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 141 Spain: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 142 Spain: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 143 Spain: Market, By Application, 2016–2023 (USD Million)
Table 144 Spain: Market, By Product and Service, 2016–2023 (USD Million)
Table 145 Spain: Market, By End User, 2016–2023 (USD Million)
Table 146 RoE: Market, By Technology, 2016–2023 (USD Million)
Table 147 RoE: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 148 RoE: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 149 RoE: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 150 RoE: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 151 RoE: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 152 RoE: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 153 RoE: Market, By Application, 2016–2023 (USD Million)
Table 154 RoE: Market, By Product and Service, 2016–2023 (USD Million)
Table 155 RoE: Market, By End User, 2016–2023 (USD Million)
Table 156 APAC: Market, By Country, 2016–2023 (USD Million)
Table 157 APAC: Market, By Technology, 2016–2023 (USD Million)
Table 158 APAC: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 159 APAC: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 160 APAC: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 161 APAC: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 162 APAC: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 163 APAC: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 164 APAC: Market, By Application, 2016–2023 (USD Million)
Table 165 APAC: Market, By Product and Service, 2016–2023 (USD Million)
Table 166 APAC: Market, By End User, 2016–2023 (USD Million)
Table 167 Japan: Market, By Technology, 2016–2023 (USD Million)
Table 168 Japan: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 169 Japan: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 170 Japan: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 171 Japan: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 172 Japan: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 173 Japan: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 174 Japan: Market, By Application, 2016–2023 (USD Million)
Table 175 Japan: Market, By Product and Service, 2016–2023 (USD Million)
Table 176 Japan: Market, By End User, 2016–2023 (USD Million)
Table 177 China: Market, By Technology, 2016–2023 (USD Million)
Table 178 China: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 179 China: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 180 China: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 181 China: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 182 China: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 183 China: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 184 China: Market, By Application, 2016–2023 (USD Million)
Table 185 China: Market, By Product and Service, 2016–2023 (USD Million)
Table 186 China: Market, By End User, 2016–2023 (USD Million)
Table 187 India: Market, By Technology, 2016–2023 (USD Million)
Table 188 India: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 189 India: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 190 India: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 191 India: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 192 India: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 193 India: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 194 India: Market, By Application, 2016–2023 (USD Million)
Table 195 India: Market, By Product and Service, 2016–2023 (USD Million)
Table 196 India: Market, By End User, 2016–2023 (USD Million)
Table 197 RoAPAC: Market, By Technology, 2016–2023 (USD Million)
Table 198 RoAPAC: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 199 RoAPAC: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 200 RoAPAC: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 201 RoAPAC: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 202 RoAPAC: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 203 RoAPAC: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 204 RoAPAC: High-Throughput Screening Market, By Application, 2016–2023 (USD Million)
Table 205 RoAPAC: Market, By Product and Service, 2016–2023 (USD Million)
Table 206 RoAPAC: High-Throughput Screening Market, By End User, 2016–2023 (USD Million)
Table 207 Latin America: High-Throughput Screening Market, By Technology, 2016–2023 (USD Million)
Table 208 Latin America: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 209 Latin America: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 210 Latin America: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 211 Latin America: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 212 Latin America: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 213 Latin America: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 214 Latin America: High-Throughput Screening Market, By Application, 2016–2023 (USD Million)
Table 215 Latin America: Market, By Product and Service, 2016–2023 (USD Million)
Table 216 Latin America: High-Throughput Screening Market, By End User, 2016–2023 (USD Million)
Table 217 Middle East and Africa: High-Throughput Screening Market, By Technology, 2016–2023 (USD Million)
Table 218 Middle East and Africa: Cell-Based Assays Market, By Type, 2016–2023 (USD Million)
Table 219 Middle East and Africa: 3D Cell Culture Market, By Type, 2016–2023 (USD Million)
Table 220 Middle East and Africa: Scaffold-Based Technologies Market, By Type, 2016–2023 (USD Million)
Table 221 Middle East and Africa: Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 222 Middle East and Africa: Animal-Derived Hydrogels Market, By Type, 2016–2023 (USD Million)
Table 223 Middle East and Africa: Scaffold-Free Technologies Market, By Type, 2016–2023 (USD Million)
Table 224 Middle East and Africa: High-Throughput Screening Market, By Application, 2016–2023 (USD Million)
Table 225 Middle East and Africa: Market, By Product and Service, 2016–2023 (USD Million)
Table 226 Middle East and Africa: High-Throughput Screening Market, By End User, 2016–2023 (USD Million)
Table 227 High-Throughput Screening Market: Company Ranking (2017)
Table 228 Growth Strategy Matrix (2014–2018)
Table 229 Product Launches and Upgrades, 2014–2018
Table 230 Partnerships, Collaborations, and Agreements, 2014–2018
Table 231 Expansions, 2014–2018
Table 232 Acquisitions, 2014–2018
Table 233 Other Developments, 2014–2018


List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews
Figure 3 Data Triangulation Methodology
Figure 4 Global HTS Market, By Product & Services, 2018 vs 2023 (USD Million)
Figure 5 Global HTS Market, By Technology, 2018 vs 2023 (USD Million)
Figure 6 Global HTS Market, By Application, 2018 vs 2023 (USD Million)
Figure 7 Global HTS Market, By End User, 2018 vs 2023 (USD Million)
Figure 8 HTS Market: Geographic Snapshot
Figure 9 Increasing R&D Spending, Growing Initiatives By Pharmaceutical and Biotechnology Companies are Driving the HTS Market
Figure 10 Developing Markets to Register Higher Growth Rates During in the Forecast Period
Figure 11 US Accounted for the Largest Share of the HTS Market in 2017
Figure 12 North America to Dominate the HTS Market During Forecast Period
Figure 13 Reagents & Assay Kits Segment Will Continue to Dominate the HTS Market By 2023
Figure 14 High-Throughput Screening Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Pharmaceutical R&D Expenditure, By Region, 2000 vs 2010 vs 2015
Figure 16 Drug Discovery Process
Figure 17 Reagents & Assay Kits to Dominate the High-Throughput Screening Products & Services Market During the Forecast Period
Figure 18 High-Throughput Screening Market, By Technology, 2018 vs 2023 (USD Million)
Figure 19 Target Identification and Validation Segment to Dominate the HTS Applications Market During the Forecast Period
Figure 20 Pharmaceutical & Biotechnology Companies Will Dominate the HTS Market in 2023
Figure 21 High-Throughput Screening Market: Geographic Growth Opportunities
Figure 22 North America: High-Throughput Screening Market Snapshot
Figure 23 Asia Pacific: High-Throughput Screening Market Snapshot
Figure 24 Key Developments, 2014–2018
Figure 25 Thermo Fisher Scientific : Company Snapshot
Figure 26 Agilent Technologies: Company Snapshot
Figure 27 Danaher: Company Snapshot
Figure 28 Perkinelmer: Company Snapshot
Figure 29 Tecan: Company Snapshot
Figure 30 Bio-Rad: Company Snapshot
Figure 31 Merck Group: Company Snapshot
Figure 32 Corning: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2220
Published ON
Apr, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the High Throughput Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home